Welcome to Palantir’s Earnings Call. We will be discussing the results announced in our press release issued prior to today’s call and posted on our Investor Relations website. During the call, we will make statements regarding our business that may be considered forward-looking within applicable securities laws, including statements regarding our outlook for the current quarter and other future periods, management’s expectations about our future financial and operational performance and other statements regarding our plans, prospects and expectations. These statements are not promises or guarantees and are subject to risks and uncertainties, which could cause them to differ materially from actual results. Information concerning those risks is available in our earnings press release distributed prior to today’s call and in our SEC filings. Palantir undertakes no obligation to update forward-looking statements, except as required by law. Further, during the course of today’s call, we will refer to certain adjusted financial measures. These non-GAAP financial measures should be considered in addition to, not as a substitute for, or in isolation from, GAAP measures. Additional information about these non-GAAP measures, including reconciliation of non-GAAP to comparable GAAP measures, is included in our press release and investor presentation provided prior to today’s call. Palantir’s press release, investor presentation and SEC filings are available on Palantir’s Investor Relations website at investors.palantir.com. With that, I’ll turn it over to Rodney.

Thanks, Jacko. Joining me on today’s call are Shyam Sankar, Chief Operating Officer, Dave Glazer, Chief Financial Officer and Kevin Kawasaki, Global Head of Business Development Over the course of the call, we will refer to various growth rates when discussing our business. These rates reflect year-over-year comparisons unless otherwise stated. I'll turn the call over to Shyam to get us started.

Thank you, Rodney. Cutting-edge product and continued efficiencies and distribution drove exceptionally strong Q1 results. Adjusted free cash flow was $151 million, a 44% margin, and this was an increase of $441 million over the year ago quarter. Revenue was up 49%, billings grew 248%, RPO grew 129%. We had 76% growth in duration adjusted commercial deal value. We had an adjusted operating margin of 34%. And our US business across government and commercial continues to be on fire growing at 81%. These results and for that matter our future results wouldn't be possible without our relentless focus on product innovation. The area I'm most excited about is the development of Apollo for Edge AI. This was demonstrated at the Dugway Proving Grounds in Utah this past April, just last month. This is live now. We are pioneering approach that we call micro models. Just like micro services are the basis of modern software architectures, we believe that micro models are how you operationalize AI at scale for enduring advantage. There is no place, this is more true than in our US government work on some of the hardest and most important problems facing our nation. Apollo for Edge AI is the next evolution to transform AI into alpha, enabling customers to train, manage and deploy multiple independently versioned chained models to the Edge with ease. Customers will have maximum flexibility to decompose a task into multiple models, where each component can be improved and upgraded in isolation, and subsequently dynamically chained together even if links in that chain are running across multiple platforms from space to mud and across different sensors and shooters, making the sum of the parts greater than the whole. This is operational AI in action at the Edge, its decision advantage delivered. And we are…

Thanks, Shyam. I'll now review our first quarter performance, followed by our outlook. Cutting edge product and increased efficiencies and distribution drove an exceptionally strong Q1 results. We generated revenue growth of 49%, bringing Q1 revenue to $341 million. Adjusted operating income increased to $117 million, representing a margin of 34%. And adjusted free cash flow increased to $151 million, representing a margin of 44% and a $441 million improvement from Q1 2020. This was backed by strong first quarter billings of $362 million, up 248% year-over-year. Looking at our revenue performance, our total first quarter revenue growth was 49%, ahead of our prior guidance of 45%. The combination of 49% revenue growth and 44% adjusted free cash flow margin is indicative of the unique underlying unit economics of our business. Our US business ended the first quarter with nearly $800 million annualized revenue run rate, as total first quarter US revenue increased 81%, representing 72% US commercial growth and 83% US government growth. Looking at revenue by segment, first quarter government revenue was $208 million, up 76%. US government revenue increased 83% year-over-year in the first quarter and international government revenue increased 57% year-over-year. We expect this momentum to continue, as we have a significant pipeline of government deals building in Q2 and beyond that we believe will fuel durable elevated growth in our government segment. First quarter commercial segment revenue totaled a $133 million, up 19% year-over-year, and we are seeing particular strength in the US, as US commercial revenue increased 72% year-over-year. In addition to that revenue growth, we're also seeing substantial increases in leads and new opportunities, and we've more than doubled the number of active pilots in our commercial business since February. Abroad and particularly in Europe, we're seeing more muted commercial growth in countries…

Great. Thanks, Dave. So we'll begin Q&A with questions from our 1.5 million shareholders submitted through se. And Shyam, I'll start with you on this first one. Avi, asks.

Does the company intend to turn into profit in 2021 or to keep using the current resources to expand?

First of all, congrats Avi on having the most voted on question. There are two numbers that we focus on. The first is adjusted free cash flow, which really is the business' ability to generate money - generate cash. And the other is adjusted operating income, which is a measure of profitability, excluding stock-based comp primarily. On cash flow, we had a swing of $441 million to deposit, generating $151 million of positive cash flow, a 44% adjusted cash flow margin. So this shows the business underlying financial strength. And on operating income, we had a 34% margin. This is demonstrating a software company that is efficiently distributing its products and shows tons and tons of product leverage. Not to mention, we're one point shy of our long-term targets that we established around the time of the listing. So it really shows that we can hit that. And so if you look at these two things together, we're proving the profitability and cash generation potential of the business. Sometimes in software, people talk about the rule of 40. The sum of your adjusted free cash flow margin and sum of your revenue growth should be greater than 40, right. Well, for us, that's 49% revenue growth in Q1, 44% adjusted free cash flow margin. That's 93%. That puts us in incredibly rare site area. We're in the top three of software companies for Q1. But I think actually, the most important thing is to realize that we're just at the beginning. We only have a handful of Fortune 500 companies. We are just starting to move down market to medium-size enterprises. Our government revenue is less than 10 basis points, less a tenth of a percent of US defense spending. We have so much exciting product vision to invest in. There's just a huge market to go after. And the most prudent thing to do is to invest aggressively to go after. And that's what we're doing. We are focused on profitability. We're focused on growth. We're focused on generating in excess of $4 billion in revenue in 2025, as Alex outlined earlier this year.

Great. Thanks, Shyam. I'll stick with you on this next one. We've gotten a few questions around the announcement, the investments that we've announced.

So Jackson K. asks, why is Palantir choosing to invest in companies such as Lilium and Sarcos Robotics? Can you speak to the motivation behind these decisions and if investors can anticipate future corresponding investments? How do you view risk, investment size and potential return?

Thanks Jackson for the question. As I mentioned throughout the call, we are relentlessly focused on increasing distribution. And here, we see a unique opportunity with ambitious companies to invest in both compelling management teams and compelling businesses and to partner with them on using our software from day zero. These are folks that are focused on winning. There is no entrenched IT bureaucracy that wants to build their own toy like solution. They viscerally understand the value of buying the best operating system for their enterprise, shaving years and mountains of risk off their road map. That's not even to make mention of all the money they would have otherwise wasted buying traditionally siloed systems from CRM to ERP to manufacturing execution systems to some homegrown mini monster. Overall, we think this is a really compelling opportunity to accelerate our business, to accelerate our distribution and to bet on our customers.

Great. And maybe one more for you, Shyam, before going to the rest of the group.

Jeffrey T. asks, what are your plans to compete with Microsoft in the coming quarters?

Thanks Jeffrey. Well, we don't compete with Microsoft or other software vendors or system integrators. We compete against our customers. We compete against our customers' desire to build their own bespoke solution. This is build versus buy. And you aren't actually buying with Microsoft or these other vendors. I mean, with Microsoft, remember Ballmer's famous meme, developers, developers, developers, or with AWS, look at their product marketing, it's about build, build better, build faster, build on AWS. The same for GCP and with system integrators, by definition, you're building. And yes, that's a challenge because our software shamanism means that we build something radically in the future, holistic in approach and stunning in its results. But it's also something that comes across as both heterodox to the high priest of IT and their reference architecture. But the proof is in the pudding when the pandemic hit and tore through our health systems and supply chain, the IT orthodoxes failed to deliver anything ameliorate. Foundry and Gotham delivered revolutionary capabilities in jaw droopingly short periods of time. Our battle tested, and I mean, that literally, our battle-tested architecture is competing against DIY market. And the pace we are innovating at continues to put distance between us and the next best alternative from archetypes that allow you to replace a year of custom integration with a few clicks over a few hours to Apollo for Edge AI that allows you to deliver the most sophisticated operational AI that is frankly just a few steps shy of Skynet. And as I mentioned earlier, we see the cloud providers, in particular, starting to incorporate these battle-tested architectures into their go-to-market motion and their offerings to their customers, precisely because selling undifferentiated LEGO bots isn't enough.

Great. Thanks, Shyam. Kevin, I'll come to you with this next one. It's kind of in the similar vein.

Donatas asks, do you see Palantir becoming as crucial and impactful as Microsoft Office for businesses? If so when do you expect to reach that kind of adoption?

Thanks for the question. People should expect more from the modern operating purpose. For our customers, particularly in a time of great need, we're the most crucial and the most impactful software for any type of business. Our users aren't just in the office. They're on the front line, on the factory floor, at an airport, doctor’s office, in a war zone. People use our product for their day-to-day job, their day-to-day mission. I think about a nursing home worker in Japan, who's caring for an aging population and needs to deliver preventative care. Workers at an airline routing thousands of flights or last year needing to find parking for thousands of aircraft. One of our customers is fighting wildfires in California, fire risk experts doing on the ground inspection with foundry. The United States and the United Kingdom governments are running two of the most successful vaccination programs in the world, and both are using foundry. In the UK thousands of users from physicians to administrators, nearly 2,500 vaccination sites, nearly 44 million vaccines. And every vaccine is ordered, allocated, tracked and delivered in foundry. In the United States, 257 million vaccines over 1,600 data sets, 50 states, 14 jurisdictions, pharmacies, manufacturers, foundry is the place for the federal government to understand vaccine supply and distribution chain from manufacturing to the jabs. Our products help our customers win, which is what is required of the modern operating system.

Thanks, Kevin. Shyam, I'll come back to you on this next one.

Johan asks, your recent partnership with Faurecia, and the one before with Airbus shows your ability to work with that manufacturing clients. Is there any plan to develop that sector even further?

Thank you, Johan. Absolutely, manufacturing is a huge focus for us and it's an area of deep, deep strength historically. Just look at Chrysler. Every factory in North America on the factory floor, you will find foundry open to manage quality in real time. Manufacturing with chemical companies, mining, energy, suppliers across ecosystems in automotive, aerospace, I'll announce a new customer, auto manufacturing with Fuzhou. We have cutting-edge products and archetypes that deliver rapid value in managing working capital, procurement, production, demand forecast, supply chain management, quality, logistics, all the whole chain around manufacturing. And I call out companies like Lilium and Sarcos again that are going to build their operations around foundry from day 0, using foundry for ERP, CRM, manufacturing execution, for quality and much more. And our value here extends beyond manufacturing into sales and after sales, turning IoT and telemetry data into real value, not only for the OEMs, for the manufacturers, but for their suppliers and their customers.

Great. Dave, I'll come to you on this next question. We've gotten a few on these lines.

Brian L asks, could you ever see Palantir having Bitcoin or any other type of cryptocurrency on its balance sheet?

Brian, thanks for the question. The short answer is yes. We're thinking about it, and we've even discussed it internally. Take a look at our balance sheet, $2.3 billion in cash at quarter end, including $151 million in adjusted free cash flow in Q1. So it's definitely on the table from a treasury perspective as well as other investments as we look across our business and beyond. On the other side of that, in terms of accepting Bitcoin from our customers, we do accept it. That's more convenient. We're open for business there.

Great. Thanks, Dave. Shyam, coming back to your question about our work in healthcare.

Conrad asks, does foundry have presence in early stage drug discovery and compound identification, not clinical trial data, but molecular properties, especially as pharma moves from small molecules to biologics?

Thanks, Conrad. Yeah, our life science work is growing very quickly, and we are absolutely working on the drug discovery end of it. I'd highlight our work with NCI, the National Cancer Institute, and the National Center for Advancing Translational Sciences at NIH, where we are doing lots of preclinical work. A small sliver, which was actually made public through published papers were Palantir and Palantirians are listed at. You can check out some of these from past ASCOs. Our work with MD Anderson spans not only obviously, clinical, but also preclinical work that we're doing, but more head on directly to just drug discovery. I'm proud to announce new partnerships with Roivant Sciences where we will work across their portfolio on drug discovery and development. And if you know anything about Roivant, they've invested a lot in computational approaches to drug discovery. With Celularity, we're going to help accelerate science around their breakthrough cell-based therapies and their cutting-edge biotechs that's focused on translating condensate biology into medicine.

Great. Thanks, Shyam. Kevin, I'll come to you on this next one, a question about the go to market.

Jackson K asks, how is Palantir planning to expand downstream to medium-sized businesses? Since demo day and the kick-off of Double Click, has Palantir seen an increase in the interest from smaller companies? And if not, how can Palantir better demonstrate value to these businesses?

I mean, short answer is yes, we signed up a number of great small and medium-sized businesses recently. And I expect to see more of this because we're widening our distribution. A big driver of our Q1 results, that's 72% commercial growth in the United States and what's contributing to the revenue guide for Q2 is our increasing efficiencies of distribution. Our sales cycle is beating up. On demo day and Double Click, demonstrating our product publicly generates interest from all over, large global multinationals tuning in across their vast organization, smaller local regional companies are turning in to - tuning in to learn how foundry can provide an edge for their business, too. And this generates activity. We mentioned that our qualified pipeline has increased by two and a half times in the US and UK. And active commercial pilots across the business have more than doubled. And I think one of the most exciting things is that our shareholders are showing up in customer meetings. Of the 1.5 million individual shareholders, some are calling so they could bring foundry to their day to day job.

Great. Kevin, I'll stick with you as next question is in the similar vein.

Christopher T. asks, with the recent announcement that Palantir is going to offer software to companies for free, how is Palantir getting this information out to Fortune 500 companies? Is Palantir reaching out to individual companies or are they waiting for - are we waiting for companies to come to us?

Thanks for this question. I suppose this is this is an opportunity to get the information out there. Over this last year, many of the most successful responses to the pandemic relied on effective data access through foundry. The purpose of Palantir unlock is to make foundry available to those who need it. I can remember about a year ago, when we were at the beginning stages of COVID-19, we knew that Palantir can make a huge impact, but we needed to help people learn this. So we began calling and calling and called city, state, local government, hospital, university research centers just to let them know that we have a technology that could help. I remember dialing into a state government. And finally, after several calls, finding the one person who's essentially trying to bring together data for the entire state with nothing more than a spreadsheet and a white board. Sitting in a war room, she was trying to figure out answers to critical question. How many hospital beds do we have? How long until we run out? How many ventilators? How long will they last? How do I get PPE to my health workers? And we're proud to say that this person had the power of foundry within hours and that is what we're offering here with unlock.

Great. So Shyam, on to next question, zooming out a little bit.

Jose asks, what is Palantir's long-term identity, both be a data and AI company or will it try to be the leader in many parts of the tech industry?

Thanks, Jose. Well, we aspire to be the most important software company in the world. And some would say that we're well on our way. We help countries deter and respond to threats from totalitarian regime. We help prevent terrorism from destroying our way of life. We enhanced the protection of data, private ship and civil liberty to prevent the reaction to terrorism from destroying our way of life. We help governments manage public health. And broadly, we have helped organizations respond to the various shocks that would otherwise have been death-row. And we do this with completely unique software. Foundry is an operating system for the modern enterprise, Gotham as defense OS, these are generational shifts in capabilities and approach. Personal computing was stuck in time before the standardization of the right operating systems. Similarly, enterprises are stuck in our site without the right modern enterprise operating business. They are either drowning in the collection of siloed applications or they're just being sold a bunch of LEGO bots and a do-it-yourself dream. Personal computer hobby has tried to make their own operating systems too. We know how well that worked out. Alex sometimes said that we are software shaman. We have this track record of seeing around the corner and building what the world needs before the need is obvious. And the ability to even have perceived the need feels mystical, and its precedent when it meets the moment. And you're going to see this again with Apollo for Edge AI.

Great. Dave, I'll come to you with this next one.

Louis asks, can you expand on Palantir's stock-based compensation will have further dilute the total shares of the company by increasing float each quarter and how much longer will significantly impact EPS?

Thanks, Louis. We have very low dilution when looking at a fully diluted share count. So far this year, our share -- fully diluted share count has increased less than two-tenths of a percent so really, really low. With respect to SBC, it will normalize over the next couple of years as we're working through this outstanding overhang. And at the same time, when you couple that with the topline growth, we're going to continue to make progress toward profitability.

I would just add that. Obviously, everything Dave said is right here. The 20 basis point shows the discipline with which we are managing dilution. But just to zoom us out for a second here, like, why do we have stock-based comp in the first place. Equity is the fundamental investor employee alignment. We want, and frankly, you should want employees working their asses off with a long-term orientation to grow the value of the company. And so yes, we plan to continue granting equity to our employees and providing them opportunities to share a meaningful upside in the company in order to maximize your shareholder value.

Great. Dave, I'll stick with you.

Jason B. asks, why does Pop Karp keep selling its shares?

Jason, thanks for the question, and nice Pop Karp reference. We'll call him Alex here. So first off, Alex is one of our largest stockholders, but he has two large option grants that are expiring at the end of December that can't be extended. And so when he goes and exercises these options, it's going to create a very, very large stock build just to exercise in holding shares. And as a result, we've seen tax motivated sales as well as many corresponding exercises for shares that he will continue to hold. And even after this, he'll continue to be one of our largest stockholders. If you're interested in the nitty-gritty, you can check our filings if you want more detail.

Great. Shyam, I'll come to you with this next one before we open up the call.

Emil asks, experience of Palantir software appears more often now on job postings. Would you consider creating courses or tutorials on how to use your software, access to of course we've given incentive for the employees to request the software for their companies. Could you comment on that?

Thanks, Emil. Indeed, the number of job postings for roles that require contract experience, they're growing every day, and that has really accelerated. Now that we have 15 large system integrators who are hiring, training and building practices around foundry, and we've built robust training to enable these system integrators to build billion-dollar lines of businesses around foundry. But to your question, we want to do even more here, especially work in help with restarting economies and returning to full employment. So we're planning to make foundry training available free to veterans of U.S. and allied militaries, to all of our individual shareholders and to anyone who is unemployed in the markets that we operate in. We are really excited about this. And we hope that it will make a meaningful contribution to restarting and reopening. So stay tuned for more details around this in the coming weeks.

Great. Operator, we'll open up the call for Q&A.

[Operator instructions] Your first question comes from Chris Merwin from Goldman Sachs. Your line is open.

All right. Thanks for taking my question and congrats on the quarter here. I wanted to ask about the commercial business. It looks like growth improved from last quarter, still below 20%. But I know there's a lot that you've been working on there, including the modularization of foundry and wanted to hear how that was resonating with customers. And then just the second part of the question would be around the customer add. It looks like you added 11 new customers on the commercial side in the quarter. Did most of this come from IBM or are those through your direct sales force? Thanks.

Great. Thanks, Chris. Yeah, the commercial business is gaining more and more momentum. As we mentioned, it grew 72% in the US. So what we're seeing is where economies are opening, there's just incredible traction there. We've hired 50 sales folks in the last quarter. You're starting to see that translate through in terms of activity two and a half times the number of qualified opportunities in the US and the UK, double the number of commercial pilots, the product investments that we've made around modularization and archetypes, those are what are translating also into increased activity. It's what's fueling our ability to do substantially more pilots here. The channel strategy is also helping us source more customers. The IBM partnership generated its first deal within 16 days of being launched there. So lots of momentum there, a place that we'll continue investing in. Overall, we're quite excited. We continue to win deals in Europe. Pharencia, Lilium in Europe, Fuzhou, Engi, so a bunch of momentum there. And as Europe starts to open and manage through the pandemic, we're also expecting the same sort of tailwind that we've seen in the US, in Europe.

Thanks so much.

And your next question will come from Parvi Provokzian from Jefferies. Your line is open.

Hey, thanks. It's Brent Thill at Jefferies. On the government business, there's a lot of questions about the sustainable strength post-COVID. And what you're seeing, I think you said in the past that COVID has opened the door to many conversations, but there's a considerable amount of long tail of that. If you could just talk to what you're seeing as you look out? Thank you.

Thanks, Brent. That's absolutely right. There are a lot of things that got started as a result of COVID, but many of those things were not related to COVID response per se. It's really the fact that something had to be delivered, and it had to work in days, it showed many of the customers where their bespoke, custom-build approach was just never going to get there and allow them to mark-to-market whether a faster buy solution was going to work. And so we've seen that across the business, of course, the work with the National Nuclear Security Administration is not directly COVID related at all, but it's certainly accelerated by this. We've seen work across healthcare, DoD, civilian agencies, accelerate inside the US and outside of the US. We've also seen that the pipeline is continuing to build there. We're expecting a lot of defense-related activity to build over the back half of the year and into next year. We participate in the global information dominance experiment with 11 combat command, that was not even visible during the contact that we build here. So quite excited about the pace at which these things are building. And if you think about Apollo for Edge AI, most of the capabilities we're looking at, they didn't even exist around the time of the listing, like the pace at which we are innovating on the product is probably one of the most exciting things and that is what is creating these opportunities that are compounding.

[Operator instructions] Your next question comes from Keith Weiss from Morgan Stanley. Your line is open.

Excellent. Thank you guys for taking the question and very nice quarter, especially with those new commercial customer adds. I had a question on kind of the margin side of the equation. And how we should be thinking about expense growth throughout the remainder of the year. So maybe to you, David. You did close to over $150 million of free cash flow in Q1. You're guiding for that figure for the full year. How should we use that to sort of guide our expectations on how that OpEx cost brand throughout the year? And how should we think about that on a go-forward basis? What's the investment philosophy if you will behind Palantir over the next couple of years as you look to sustain that 30% plus growth?

Absolutely, absolutely. So as you noted, we had a very strong quarter, 49% revenue growth, 44% adjusted free cash flow margin and 34% adjusted operating margin. There's nothing noteworthy to call out on the expense side. Top line being obviously a contributor there. Overall, super pleased with the results. It shows the underlying unit economics. Let's look ahead to Q2, very strong revenue guide of 43% growth, coupled out with 23% operating margin, while at the same time, we're really going to be investing into the business, investing in sales hires, investments around the sales team, continued investment in the product and R&D, a lot of what Shyam talked about. And we're going to be focused on reopening. We think it's really important to get the company back in the offices to get people together and focus on culture.

And your next question will come from Alex Zukin from Wolfe. Your line is open.

Hey, guys. Thank you for the question. I wanted to ask clearly, the confidence in the commercial revenue growth is high given the rep hiring that you guys are putting up. Can you talk about the divergence in pilots in the commercial sector versus the stated revenue growth? And when will those pilots convert to revenues? How visible is that conversion time line, et cetera?

Yes. We're quite excited by the teeth [ph] at which our hires are being accomplished, the ramp that we're seeing for those tires. We're also seeing just a kind of aggregate flywheel acceleration where the ramps are getting faster, the activity, converting into revenue is getting faster. So generally I would agree like we are feeling very bullish, and we're seeing that there. The pilots themselves are compressing in terms of how long they're taking because of the investments made in product modularization, archetypes, these allow us to structure the products in a way that something that would have taken three months to four is now a week or less. This is giving us a lot more capacity to cost efficiently distribute the product, accomplish these pilots and turn the revenue crank here. And so we're seeing very high returns to the sales force we're building. We want to keep doing more here. Look for that to accelerate even further in the back half of the year. And the conversion, we're really happy with it. I think when I just think about the two and a half x qualified pipeline that's been created since February 1, and then I think about the doubling of the pilot we're seeing about a third of those have already turned into something. And so as we build bigger and bigger pipeline here, we're feeling good about how that funnel is flowing through. And if you combine that with the additional product investments, the road map that we're executing on, we have every reason to believe that we're going to continue to see acceleration across all these dimensions.

This brings us to the end of our audio Q&A session. I turn the call back over for closing remarks.

Thank you all for joining us. We're excited about the quarter. Thank you for waking up early. We'll talk to you all soon.

Thank you, everyone. This will conclude today’s conference call. You may now disconnect.